Liquid Biopsies: Paving the Path for NGS-Based Biomarker Discovery


Liquid biopsy samples are increasingly becoming one of the most valuable, minimally-invasive sources of information as the basis of diagnosis and disease monitoring as well as disease prevention. Biospecimens such as plasma, serum and urine contain various biomarkers that provide key insights into changes within the genome, epigenome, transcriptome and proteome of a patient.

June 15, 2022 | 10:30 AM EDT

Read More

Next Post

ESG on the Balance Sheet

Health equity and sustainability are two areas in which healthcare organizations would be wise to invest, given their potential to impact the balance sheet. In the coming years, health equity outcome-related data will increasingly impact reimbursements, policies from the executive branch, as well as the Centers for Medicare & Medicaid […]